SCHEMBL4112966

SCHEMBL4112966

C=CCC(N)=O.CC(CC(N)=O)CC(N)=O

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31
TSHR P16473 1/20 0.31
FGFR4 P22455 1/20 0.31
ECE1 P42892 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3392036 0.81 ALDH1A1 (0.38) ALDH1A1TSHRECE1
SCHEMBL22988 0.81
Propene SCHEMBL28173463 0.79
Acetamide SCHEMBL11146504 0.79 LMNA (0.44) ALDH1A1TSHRFGFR4
SCHEMBL29037934 0.78
Ethylene SCHEMBL11309737 0.78
Hydrochloric Acid SCHEMBL1444802 0.78
Acetamide SCHEMBL4103797 0.76 LMNA (0.47) ALDH1A1ECE1
SCHEMBL5770692 0.72
SCHEMBL939129 0.72 BHMT (0.42) ALDH1A1ECE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090226392-A1 Phosphate-Binding Polymers for Oral Administration GELTEX, INC. 2009-09-10 US disclosed
US-7459151-B2 Phosphate-binding polymers for oral administration GENZYME CORPORATION (US) 2008-12-02 US disclosed
US-20060171916-A1 Phosphate-binding polymers for oral administration HOLMES-FARLEY STEPHEN R 2006-08-03 US disclosed
US-7014846-B2 Phosphate-binding polymers for oral administration GENZYME CORPORATION (US) 2006-03-21 US disclosed
US-6858203-B2 Method of making phosphate-binding polymers for oral administration GENZYME CORPORATION (US) 2005-02-22 US disclosed
US-20040191212-A1 Phosphate-binding polymers for oral administration GENZYME CORPORATION (US) 2004-09-30 US disclosed
US-20030133902-A1 Method of making phosphate-binding polymers for oral administration GELTEX PHARMACEUTICALS, INC. 2003-07-17 US disclosed
US-6509013-B1 Water insoluble crosslinked allyl amine homo- or copolymer and carrier; removing phosphate from gastrointestinal tract; hyperphosphatemia GELTEX PHARMACEUTICALS, INC. 2003-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090226392-A1 Phosphate-Binding Polymers for Oral Administration PHPT1, SLC34A2, ALPI ALDH1A1 4687/4885TSHR 2200/4885FGFR4 1087/4885
US-20030133902-A1 Method of making phosphate-binding polymers for oral administration SI, PHPT1, ALPI ALDH1A1 4548/4885TSHR 2710/4885FGFR4 1825/4885
US-20040191212-A1 Phosphate-binding polymers for oral administration PHPT1, SLC34A2, ALPI ALDH1A1 4687/4885TSHR 2200/4885FGFR4 1087/4885
US-20060171916-A1 Phosphate-binding polymers for oral administration PHPT1, SLC34A2, ALPI ALDH1A1 4687/4885TSHR 2200/4885FGFR4 1087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.